Related Experiment Video
Updated: Feb 14, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Ivabradine for systolic heart failure
Courtney M Meade1, Jennifer N Clements
1At the time this article was written, Courtney M. Meade was a student in the Presbyterian College School of Pharmacy in Clinton, S.C. Jennifer N. Clements is associate professor of pharmacy practice in the Presbyterian College School of Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Ivabradine works in the sinoatrial node to prolong diastolic depolarization and reduce heart rate. In patients with chronic systolic heart failure, this drug has reduced the risk of hospitalization when used in combination with other optimal pharmacotherapy.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

